Finch Therapeutics Group Inc (FNCH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FNCH Annual Balance Sheets →
A period-by-period view of the balance sheet from Finch Therapeutics Group Inc to Jun 30 2023 helps clarify how Jun 30 2024's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent16.04
Cash & Short-term Investments16.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.24
Total Current Assets17.28
Equipment/Property/Plant Net0.51
Other Assets, Noncurrent26.00
Restricted Cash Noncurrent2.35
Total Assets45.58
Liabilities
Accounts Payable, Current AC0.03
Other Liabilities, Current4.43
Total Current Liabilities4.46
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Current Liabilities2.34
Operating Lease Liability Noncurrent26.90
Total Liabilities31.36
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock373.32
Retained Earnings / Accumulated Deficit-359.11
Other Equity0.00
Common Stockholder's Equity14.22
Total Stockholder's Equity14.22
Liabilities & Stockholder's Equity45.58
4 historic quarters locked

Sign in to unlock the full Finch Therapeutics Group Inc balance sheet history.

About Finch Therapeutics Group Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-096246

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.